Published in J Clin Microbiol on July 03, 2012
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis (2015) 1.14
Microbial communities in the respiratory tract of patients with interstitial lung disease. Thorax (2013) 1.08
Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals. Am J Respir Crit Care Med (2015) 1.01
The lung microbiome of Ugandan HIV-infected pneumonia patients is compositionally and functionally distinct from that of San Franciscan patients. PLoS One (2014) 1.00
Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol (2014) 1.00
Metabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls. AIDS Res Hum Retroviruses (2014) 1.00
The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med (2014) 1.00
Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc (2014) 0.95
Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa. BMC Microbiol (2014) 0.85
Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J (2015) 0.85
Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection. Microbiome (2016) 0.84
Microbiome in human immunodeficiency virus infection. Clin Lab Med (2014) 0.82
The hidden 'mycobacteriome' of the human healthy oral cavity and upper respiratory tract. J Oral Microbiol (2015) 0.80
The microbiome of the human lower airways: a next generation sequencing perspective. World Allergy Organ J (2015) 0.79
Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in HIV-Pneumonia Patients. Am J Respir Crit Care Med (2016) 0.78
Red fluorescent biofilm: the thick, the old, and the cariogenic. J Oral Microbiol (2016) 0.78
Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome. Int J Mol Sci (2015) 0.76
The impact of different methods of DNA extraction on microbial community measures of BALF samples based on metagenomic data. Am J Transl Res (2016) 0.75
Mycoplasma pneumoniae and Streptococcus pneumoniae caused different microbial structure and correlation network in lung microbiota. J Thorac Dis (2016) 0.75
Lung microbiome in human immunodeficiency virus infection. Transl Res (2016) 0.75
The respiratory microbiome of HIV-infected individuals. Expert Rev Anti Infect Ther (2016) 0.75
Mucociliary dysfunction in HIV and smoked substance abuse. Front Microbiol (2015) 0.75
Disruption of the microbiota across multiple body sites in critically ill children. Microbiome (2016) 0.75
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol (2006) 57.72
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res (2008) 52.43
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Bacterial community variation in human body habitats across space and time. Science (2009) 24.84
The NIH Human Microbiome Project. Genome Res (2009) 24.61
Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08
Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A (2010) 7.09
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet (2005) 6.60
Disordered microbial communities in asthmatic airways. PLoS One (2010) 6.35
High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol (2007) 4.81
Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med (2011) 4.78
Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res (2008) 4.71
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation. Appl Environ Microbiol (2006) 4.09
Implication of the mosquito midgut microbiota in the defense against malaria parasites. PLoS Pathog (2009) 3.71
Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J (2010) 3.39
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One (2010) 3.38
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun (2009) 3.36
Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol (2003) 3.09
Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) (1997) 2.82
Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio (2010) 2.53
A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS (2010) 2.42
Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol (2007) 2.12
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med (1987) 2.04
Oral health and respiratory infection. J Can Dent Assoc (2002) 1.45
Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One (2010) 1.38
Enumeration of Archaea and Bacteria in seafloor basalt using real-time quantitative PCR and fluorescence microscopy. FEMS Microbiol Lett (2008) 1.29
Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children. J Pediatr (2008) 1.26
Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan. Emerg Infect Dis (2000) 1.26
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis (1991) 1.06
Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus. Clin Infect Dis (1994) 1.05
Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care STDS (2009) 1.00
Pneumonia in nonambulatory patients. The role of oral bacteria and oral hygiene. J Am Dent Assoc (2006) 0.99
HIV infection associated with Strongyloides stercoralis colitis resulting in Streptococcus bovis bacteraemia and meningitis. Sex Transm Infect (2005) 0.85
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One (2010) 3.38
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med (2010) 3.00
Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis (2004) 2.70
Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci (2009) 2.60
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis (2011) 2.59
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol (2010) 2.55
Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio (2010) 2.53
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med (2013) 2.47
A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS (2010) 2.42
Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS (2003) 2.18
Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med (2002) 2.12
Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS (2008) 2.12
Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am J Respir Crit Care Med (2008) 2.10
Man's best friend? The effect of pet ownership on house dust microbial communities. J Allergy Clin Immunol (2010) 2.06
Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med (2004) 2.05
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Integrated strategies to optimize sputum smear microscopy: a prospective observational study. Am J Respir Crit Care Med (2010) 1.95
Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis (2011) 1.95
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2011) 1.95
Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest (2008) 1.94
Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis (2009) 1.92
Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis (2008) 1.89
House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci U S A (2013) 1.88
Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. Crit Care Med (2008) 1.82
Causes of early mortality in HIV-infected TB suspects in an East African referral hospital. J Acquir Immune Defic Syndr (2010) 1.81
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa. Anesthesiology (2007) 1.73
Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One (2009) 1.71
Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med (2013) 1.71
Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications. J Infect Dis (2005) 1.69
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Current issues in critical care of the human immunodeficiency virus-infected patient. Crit Care Med (2006) 1.62
Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys (2007) 1.57
Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study. PLoS One (2010) 1.54
Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda. PLoS One (2012) 1.52
Environmental risk factors for Pneumocystis pneumonia hospitalizations in HIV patients. Clin Infect Dis (2012) 1.48
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med (2011) 1.43
Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir. J Virol (2003) 1.40
Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One (2010) 1.38
A mentor development program for clinical translational science faculty leads to sustained, improved confidence in mentoring skills. Clin Transl Sci (2012) 1.38
Effect of prenatal indoor pet exposure on the trajectory of total IgE levels in early childhood. J Allergy Clin Immunol (2011) 1.32
Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS (2005) 1.32
ChrR, a soluble quinone reductase of Pseudomonas putida that defends against H2O2. J Biol Chem (2005) 1.26
Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services. Am J Respir Crit Care Med (2011) 1.24
Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr (2013) 1.23
HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc (2011) 1.18
An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP). Proc Am Thorac Soc (2006) 1.16
Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda. J Clin Microbiol (2008) 1.16
A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis (2004) 1.15
The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda. J Acquir Immune Defic Syndr (2010) 1.13
High sensitivity and specificity of acid-fast microscopy for diagnosis of pulmonary tuberculosis in an African population with a high prevalence of human immunodeficiency virus. J Clin Microbiol (2009) 1.12
Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. PLoS One (2012) 1.07
HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr (2013) 1.07
Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis (2010) 1.07
Antibody response to Pneumocystis jirovecii major surface glycoprotein. Emerg Infect Dis (2006) 1.06
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts. PLoS One (2013) 1.06
HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 1.05
Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants. Gut Microbes (2010) 1.04
Pseudomonas aeruginosa biofilm-associated homoserine lactone C12 rapidly activates apoptosis in airway epithelia. Cell Microbiol (2012) 1.04
Update on the epidemiology and transmission of Pneumocystis carinii. Microbes Infect (2002) 1.03
Development of an automated gamma-H2AX immunocytochemistry assay. Radiat Res (2009) 1.01
New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution. Mol Cancer Ther (2006) 1.00
Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii. J Infect Dis (2002) 1.00
Gut dysbiosis in cystic fibrosis. J Cyst Fibros (2012) 0.98
Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study. PLoS One (2011) 0.98
The microbiome and the lung. Ann Am Thorac Soc (2014) 0.97
The effect of ultrasound stimulation on the gene and protein expression of chondrocytes seeded in chitosan scaffolds. J Tissue Eng Regen Med (2011) 0.97
Microbial manipulation of immune function for asthma prevention: inferences from clinical trials. Proc Am Thorac Soc (2007) 0.97
Strain-dependent induction of neutrophil histamine production and cell death by Pseudomonas aeruginosa. J Leukoc Biol (2011) 0.97
Role of small GTPases and alphavbeta5 integrin in Pseudomonas aeruginosa-induced increase in lung endothelial permeability. Am J Respir Cell Mol Biol (2008) 0.96
Genetic diversity of Pneumocystis carinii f. sp. hominis based on variations in nucleotide sequences of internal transcribed spacers of rRNA genes. J Clin Microbiol (2002) 0.95
Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates. J Infect Dis (2009) 0.94
Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease. Am J Respir Crit Care Med (2015) 0.93
Developement of serum-free media in CHO-DG44 cells using a central composite statistical design. Cytotechnology (2007) 0.93
True duplication of the vas deferens: a case report and review of literature. Int Urol Nephrol (2011) 0.93
Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts. BMC Pulm Med (2014) 0.93
Healthcare worker occupation and immune response to Pneumocystis jirovecii. Emerg Infect Dis (2009) 0.92
Critical illness in HIV-infected patients in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 0.92
Clinical significance of normal chest radiographs among HIV-seropositive patients with suspected tuberculosis in Uganda. Respirology (2011) 0.92
Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients. PLoS One (2010) 0.92
Clinical and radiographic predictors of the etiology of computed tomography-diagnosed intrathoracic lymphadenopathy in HIV-infected patients. J Acquir Immune Defic Syndr (2002) 0.91
Implementation of a methicillin-resistant Staphylococcus aureus (MRSA) prevention bundle results in decreased MRSA surgical site infections. Am J Surg (2009) 0.91
Integrin-mediated mechanotransduction pathway of low-intensity continuous ultrasound in human chondrocytes. Ultrasound Med Biol (2012) 0.91
HIV infection is associated with diffusing capacity impairment in women. J Acquir Immune Defic Syndr (2013) 0.91
Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis (2009) 0.91